View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Moody's assigns Baa2 to Zimmer Biomet Holdings, Inc. new senior unsecu...

Moody's Investors Service ("Moody's") assigns Baa2 rating to Zimmer Biomet Holdings, Inc. ("ZBH") or ("Zimmer Biomet") proposed $500 million senior unsecured notes.  There are no changes to the existing Baa2 senior unsecured ratings. The outlook remains unchanged at stable. Proceeds from the new $...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: November 18, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Zimmer Biomet Holdings Inc: 1 director

A director at Zimmer Biomet Holdings Inc bought 2,135 shares at 104.750USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: Sept 1, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: August 30, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: August 25, 2023

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Zimmer Biomet Holdings, Inc.: Discussion of Key Credit Factors Followi...

Our credit view of this issuer reflects its healthy EBITDA margins and strong free cash flow generation, offset by its high concentration in orthopedics.

Moody's upgrades Zimmer Biomet to Baa2; outlook is stable

Moody's Investors Service (Moody's) upgraded the senior unsecured ratings of Zimmer Biomet Holdings, Inc. ("ZBH") to Baa2 from Baa3. The outlook is stable. The ratings upgrade reflects the ongoing deleveraging and improved operating performance due to strong demand and operational improvements tha...

Zimmer Biomet Holdings, Inc.: Discussion of Key Credit Factors

Our credit view of this issuer reflects its leading market position in knee and hip implants, against its high concentration in orthopedics.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch